Transaction Case Studies


Situation Assessment

  • C4 Therapeutics is a private biotech with a novel targeted protein
    degradation platform and pipeline of pre-IND therapeutics in oncology
  • C4 Therapeutics was seeking funding to advance the current pipeline to proof-of-concept and position the company for a successful IPO
  • At the time of engagement, C4 Therapeutics had received a term sheet for Perceptive Advisors for a $115M+ Series B round
  • LW was engaged to prepare marketing materials, advise on the financing, build out the syndicate, and coordinate the closing

Key Activities

  • Prepared high-impact marketing materials distilling complicated science
    into an understandable management presentation and teaser
  • Conducted targeted outreach campaign to top-tier global and regional life-science focused investors to build out the syndicate in April 2020
  • Hosted a fully virtual roadshow with investors and led investors through virtual due diligence process
  • Conducted financial analysis to guide the deal sizing and pricing
  • Provided extensive guidance on deal dynamics and worked in collaboration with legal teams to drive financing to close

Successful Outcome

  • C4 Therapeutics successfully raised an upsized $150M Series B financing co-led by Perceptive Advisors and Cobro Opportunity Fund with a global syndicate of leading life sciences investors 
  • In volatile funding environment, Locust Walk was integral to guiding investors and the Company to a successful closing of the financing

Press Release

Back to transactions »